Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [31] Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia
    Benlian, Pascale
    Turquet, Anne
    Carrat, Fabrice
    Amsellem, Sabine
    Sanchez, Lydie
    Briffaut, Dorothee
    Girardet, Jean Philippe
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 48 (04) : 456 - 463
  • [32] Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia
    Merran Macpherson
    Bengt Hamrén
    Marjet J. A. M. Braamskamp
    John J. P. Kastelein
    Torbjörn Lundström
    Paul D. Martin
    European Journal of Clinical Pharmacology, 2016, 72 : 19 - 27
  • [33] Maternal Heterozygous Familial Hypercholesterolemia and Its Consequences for Mother and Child
    Rutherford, John D.
    CIRCULATION, 2011, 124 (15) : 1599 - 1601
  • [34] Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
    Wozniak, Ewelina
    Broncel, Marlena
    Wozniak, Agnieszka
    Satala, Joanna
    Pawlos, Agnieszka
    Bukowska, Bozena
    Gorzelak-Pabis, Paulina
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [35] Treatment of heterozygous familial hypercholesterolemia: what does the future hold?
    Polychronopoulos, Georgios
    Tziomalos, Konstantinos
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (11) : 1229 - 1233
  • [36] Evaluation of knowledge and practices regarding heterozygous familial hypercholesterolemia in children
    Jeangeorges, A.
    Rubio, A.
    ARCHIVES DE PEDIATRIE, 2018, 25 (02): : 107 - 111
  • [37] Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Sugisawa, Takako
    Makino, Hisashi
    Abe, Mitsuru
    Tsushima, Motoo
    Yoshimasa, Yasunao
    Yamashita, Takahiro
    Miyamoto, Yoshihiro
    Yamamoto, Akira
    Tomoike, Hitonobu
    Yokoyama, Shinji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (07) : 667 - 674
  • [38] Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia
    Korneva, Viktoria
    Kuznetsova, Tatiana
    Julius, Ulrich
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 79 - 87
  • [39] Early Left Ventricular Abnormalities in Children with Heterozygous Familial Hypercholesterolemia
    Di Salvo, Giovanni
    D'Aiello, Angelo Fabio
    Castaldi, Biagio
    Fadel, Bahaa
    Limongelli, Giuseppe
    D'Andrea, Antonello
    Pergola, Valeria
    Pacileo, Giuseppe
    Del Giudice, Emanuele Miraglia
    Perrone, Laura
    Calabro, Raffaele
    Russo, Maria Giovanna
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2012, 25 (10) : 1075 - 1082
  • [40] Association of heterozygous familial hypercholesterolemia with smaller HDL particle size
    Hogue, Jean-Charles
    Lamarche, Benoit
    Gaudet, Daniel
    Tremblay, Andre J.
    Despres, Jean-Pierre
    Bergeron, Jean
    Gagne, Claude
    Couture, Patrick
    ATHEROSCLEROSIS, 2007, 190 (02) : 429 - 435